VFA
MREO

Valeo Financial Advisors’s Mereo BioPharma MREO Stock Holding History

Valeo Financial Advisors’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,506
Closed -$54K – 620
2021
Q3 		$54K Sell
22,506
-10,000
-31% -$26.5K ﹤0.01% 551
2021
Q2 		$103K Buy
32,506
+25,000
+333% +$83.9K 0.01% 468
2021
Q1 		$25K Buy
7,506
+7,500
+125,000% +$26.5K ﹤0.01% 1097
2020
Q4 		$0 Hold
6
– – ﹤0.01% 1775
2020
Q3 		$0 Hold
6
– – ﹤0.01% 1938
2020
Q2 		$0 Hold
6
– – ﹤0.01% 2108
2020
Q1 		$0 Hold
6
– – ﹤0.01% 1869
2019
Q4 		$0 Hold
6
– – ﹤0.01% 1680
2019
Q3 		$0 Buy
+6
New +$18 ﹤0.01% 1631

Other funds holding MREO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Valeo Financial Advisors's MREO Position: Q4 2021 in Review

Valeo Financial Advisors sold out of Mereo BioPharma (MREO) in Q4 2021, closing a stake of 22,506 shares — an estimated $54K sold.

Valeo Financial Advisors first reported a position in MREO in Q3 2019 and held it in 9 quarters. The position peaked at $103K in Q2 2021. 72 funds tracked by Wall St. Rank hold MREO as of Q4 2021.

  • Valeo Financial Advisors reported no remaining Mereo BioPharma position as of Q4 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 22,506 Mereo BioPharma shares in Q4 2021, an estimated $54K.
  • Valeo Financial Advisors first reported a position in Mereo BioPharma in Q3 2019 and held it in 9 quarters.
  • Valeo Financial Advisors's Mereo BioPharma position peaked at $103K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2021.

Based on Valeo Financial Advisors's 13F filing for Q4 2021, filed 7 Jan 2022.